FDA Clearance Tracker · P100046-S013
AtriCure Synergy Ablation System
Last checked: Nov 20, 2026Latest source record: Nov 15, 2022 (this decision)Source: openFDAMethods & limitations
Decided
Nov 15, 2022
Approved
Time to decision
259 days
Received Mar 1, 2022. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P100046-S013
- Device name
- AtriCure Synergy Ablation System
- Applicant
- AtriCure, Inc.
- Applicant location
- Mason, OH
- Received
- Mar 1, 2022
- Decided
- Nov 15, 2022
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P100046
Device type
- Device class
- Class III
- Specialty
- CardiologyElectrophysiology
FDA's approval statement
As written in FDA's record.
Approval for the AtriCure Multifunctional Ablation Generator (MAG) as part of the Synergy Ablation System for use with the Isolator® Synergy Clamp (OLL2 and OSL2).
Source documents
Other decisions for AtriCure, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K263319 · Decided Oct 21, 2026 · 30 days after receipt
Device type: Left Atrial Appendage Clip, Implantable (PZX) · General & Plastic Surgery
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.